{
    "eid": "2-s2.0-85061900274",
    "title": "Real-World Effectiveness of High- Versus Moderate-Intensity Statin Therapy in Thai Patients With Acute Coronary Syndrome and Who Had Undergone Primary Percutaneous Coronary Intervention",
    "cover-date": "2020-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "cardiology",
        "LDL-C goal",
        "primary PCI",
        "statin intensity",
        "STEMI"
    ],
    "authors": [
        "Yotsaya Kunlamas",
        "Nutthada Areepium",
        "Aekarach Ariyachaipanich",
        "Krittin Bunditanukul"
    ],
    "citedby-count": 1,
    "ref-count": 21,
    "ref-list": [
        "Acute coronary syndromes: diagnosis and management, part I",
        "2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines",
        "Statins, percutaneous coronary intervention and myocardial infarction",
        "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials",
        "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines",
        "2016 ESC/EAS guidelines for the management of dyslipidaemias",
        "Ezetimibe added to statin therapy after acute coronary syndromes",
        "Evolocumab and clinical outcomes in patients with cardiovascular disease",
        "2017 focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk",
        "Racial differences in the cholesterol-lowering effect of statin",
        "Do singapore patients require lower doses of statins? The SGH Lipid Clinic experience",
        "Drug class reviews",
        "Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world",
        "Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients",
        "Demographic determinants of response to statin medications",
        "Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies",
        "Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients",
        "Achievement of LDL-cholesterol goal with statins after an ST segment elevation myocardial infarction",
        "Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency",
        "Effects of simvastatin 20 mg/d on serum lipid profiles in Japanese hyperlipidemic patients: a prospective, open-label pilot study"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Cardiac Center",
        "King Chulalongkorn Memorial Hospital",
        "Division of Cardiovascular Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University"
    ]
}